Takeda Pharmaceutical Company Limited
TAK · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $107,928 | $144,067 | $317,038 | $230,166 |
| Dep. & Amort. | $761,396 | $728,002 | $664,400 | $583,151 |
| Deferred Tax | $0 | -$91,406 | $58,052 | $72,405 |
| Stock-Based Comp. | $72,867 | $70,871 | $60,672 | $43,374 |
| Change in WC | -$52,254 | -$256,003 | -$25,264 | $98,605 |
| Other Non-Cash | $167,245 | $120,813 | -$97,742 | $95,404 |
| Operating Cash Flow | $1,057,182 | $716,344 | $977,156 | $1,123,105 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$200,795 | -$175,420 | -$633,689 | -$186,037 |
| Net Acquisitions | $0 | -$4,735 | $7,958 | -$21,476 |
| Inv. Purchases | $0 | -$40,066 | -$10,151 | -$8,341 |
| Inv. Sales/Matur. | $0 | $8,021 | $22,254 | $16,921 |
| Other Inv. Act. | -$166,265 | -$251,662 | $6,526 | $808 |
| Investing Cash Flow | -$367,060 | -$463,862 | -$607,102 | -$198,125 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$314,314 | $1,513 | -$285,071 | -$600,477 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$51,860 | -$2,326 | -$26,929 | -$77,531 |
| Dividends Paid | -$302,498 | -$287,188 | -$279,416 | -$283,665 |
| Other Fin. Act. | -$82,753 | -$66,415 | -$117,732 | -$108,592 |
| Financing Cash Flow | -$751,425 | -$354,416 | -$709,148 | -$1,070,265 |
| Forex Effect | -$11,385 | $26,204 | $22,929 | $28,758 |
| Net Chg. in Cash | -$72,687 | -$75,730 | -$316,165 | -$116,527 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $457,800 | $533,530 | $849,695 | $966,222 |
| End Cash | $385,113 | $457,800 | $533,530 | $849,695 |
| Free Cash Flow | $856,387 | $235,614 | $343,467 | $937,068 |